A phase I trial of the oral cyclin dependent kinase inhibitor CYC202 in patients with advanced malignancy - Concepedia

Concepedia

Publication | Closed Access

A phase I trial of the oral cyclin dependent kinase inhibitor CYC202 in patients with advanced malignancy

14

Citations

0

References

2004

Year

Jeff White, J Cassidy, Chris Twelves, Charlotte Benson, Simon Pacey, Ian Judson, Helen E. McGrath, Fiorenza De Rose, Lisa M. Frenz

Journal of Clinical Oncology

Abstract

3042